Oman to fast-track nods to Indian pharma products registered by US, UK, EuropeOman has also requested India to consider negotiating a preferential trade agreement, the commerce and industry ministry said.
NTAGI to consider administering 'additional' dose of COVID-19 vaccine to immunocompromised peopleA booster dose is given to an individual after a predefined period when the immune response due to primary vaccination is presumed to have ...
Hold Indoco Remedies, target Rs 190: ICICI DirectHold Indoco Remedies Ltd. at a price target of Rs 190.0 .
Cadila, Torrent Pharma, GSK in race for top-selling multivitamin brandApex Labs pioneered the introduction of zinc-based formulations in the Indian market and the company's flagship brand Zincovit is the brand...
Alkem's Taloja facility gets clean chit by UK health regulatorThe company on Tuesday announced the closure of the inspection by the UKMHRA for its its bio-equivalence facility in Taloja.
Alkem Laboratories slips nearly 7% on receiving 8 observations from UKMHRA"The company will submit the responses within the timeline stipulated by the UKMHRA. It does not anticipate any impact on its existing regi...
Alkem gets 8 observations from UKMHRA for Taloja plantDrug firm Alkem Laboratories today said UK health regulator has made eight observations after inspecting its manufacturing plant at Taloja,...
- Indoco Remedies gets USFDA nod for Goa solid dosages plant
Indoco Remedies today said it has received an approval from the US Food and Drug Administration (USFDA) for its solid dosages manufacturing...
Wockhardt's Chikalthana plant gets GMP certificate from UKMHRAIn a major relief to drug firm Wockhardt, its Chikalthana plant at Aurangabad in Maharashtra has received a good manufacturing practice cer...
Wockhardt plunges over 8% as Q4 net profit slips to Rs 74.45 croreThe company had posted a net profit of Rs 334.76 crore in the corresponding period of the previous fiscal, Wockhardt said in a filing to th...
Wockhardt Q4 Net plunges 78 per cent to Rs 74.45 croreThe company had posted a net profit of Rs 334.76 crore in the corresponding period of the previous fiscal, Wockhardt said in a filing to th...
Wockhardt's Chikalthana plant hit by USFDA import restrictionsIn May, the USFDA had also issued an import alert on the company's Waluj facility which makes injectables and solid dosages.
Wockhardt rallies 11% after UK regulator eased restrictions on Kadiya unitUKMHRA had imposed restrictions on import of medicines made at the Mumbai-based firm's unit at Kadaiya for violation of norms.
Wockhardt may face £1 million hit due to Kadaiya unit lapsesWockhardt today said it will take a revenue hit of nearly one million pounds due to import restrictions imposed by the UK health regulator ...
Wockhardt drops 5%, locked in lower circuit as UK health regulator withdraws certificationThe stock is now locked in lower circuit at Rs 499.30. It has lost nearly 10% in the month of October as compared to over 60% fall so far i...
UK health regulator withdraws certification of Wockhardt unitThe impact of the same on existing business will only be known once the company receives further communication from UKMHRA, Wockhardt said.
- Lupin allots shares to foreign funds
Lupin Ltd says it has alloted 783,181 equity shares upon conversion of FCCBs worth $9.60 million to foreign funds.